Publications found:
345
Sort by:
Amitriptyline Hydrochloride Market Size, Share & Trends Analysis Report By Dosage Form, (Oral Solid Dosage Forms, Oral Liquid Formulations), By Indication, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global amitriptyline hydrochloride market size was estimated at USD 381.17 million in 2025 and is projected to reach USD 510.20 million by 2033, growing at a CAGR of 3.78% from 2026 to 2033. The g...
March 2026
150 pages
Acute Agitation and Aggression Treatment Market 2026
US$ 2,999.00
The Acute Agitation and Aggression Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.05 from 2026 to 2032. The report delivers in-depth insights into key market dynamic...
February 2026
219 pages
Anticonvulsants Market 2026
US$ 2,999.00
The Anticonvulsants Market was valued at in and is anticipated to reach by , at a CAGR of 0.022 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gr...
February 2026
243 pages
Multiple Sclerosis Therapeutics Market - 2024-2033
US$ 2,999.00
The Multiple Sclerosis Therapeutics Market was valued at US$ 27.42 Billion in 2024 and is anticipated to reach US$ 46.22 Billion by 2033, at a CAGR of 0.061 from 2026 to 2032. The report delivers in-d...
February 2026
210 pages
Cervical Dystonia Market 2026
US$ 2,999.00
The Cervical Dystonia Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gr...
February 2026
200 pages
Neuroprotective Agents: Therapeutic Applications and Global Markets
US$ 4,650.00
... from neurological disorders, including stroke, Alzheimer’s disease, epilepsy, Parkinson’s disease (PD), ... suffer from a traumatic central nervous system (CNS) injury each year ... disease. Neuroprotective agents in global markets and clinical pipelines include small molecule drugs, therapeutic monoclonal antibodies ...
February 2026
186 pages
Benzodiazepine Drugs Market 2026
US$ 2,999.00
The Benzodiazepine Drugs Market was valued at in and is anticipated to reach by , at a CAGR of 0.0229 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regio...
February 2026
207 pages
Gabapentin Market 2026
US$ 2,999.00
The Gabapentin Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth tr...
January 2026
210 pages
Major Depressive Disorder Market - 2024-2033
US$ 2,999.00
The Major Depressive Disorder Market was valued at US$ 6.84 billion in 2024 and is anticipated to reach US$ 14.57 billion by 2033, at a CAGR of 0.088 from 2026 to 2032. The report delivers in-depth in...
January 2026
217 pages
Acute Migraine Drugs Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Treatment (Preventive, Pain Relieving), By Route of Administration (Oral, Injectable, Nasal Sprays, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Acute Migraine Drugs Market is projected to expand from USD 2.32 Billion in 2025 to USD 3.11 Billion by 2031, registering a CAGR of 5.01%. These pharmaceutical interventions are specificall...
January 2026
180 pages
Risperidone Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Route Of Administration (Injectable, Oral, Parenteral), By Application (Schizophrenia, Bipolar Disorder, Irritability Associated with Autistic Disorder, Others), By End-Users (Hospitals, Homecare, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Risperidone Market is projected to expand from USD 6.36 Billion in 2025 to USD 8.58 Billion by 2031, reflecting a CAGR of 5.12%. As an atypical antipsychotic, risperidone is primarily emplo...
January 2026
185 pages
CGRP Inhibitor Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Preventive, Acute), By Route of Administration (Oral, Nasal, Intravenous), By End-User (Hospitals, Pharmacies, Specialty Clinics) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global CGRP Inhibitor Market is projected to expand from USD 3.62 Billion in 2025 to USD 6.32 Billion by 2031, achieving a CAGR of 9.73%. These inhibitors represent a specialized category of pharm...
January 2026
185 pages
Insomnia Pharmacological Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug (OTC Drugs, OTC Sleep Aids, OTC Sleep Supplements, Prescription Drugs), By Treatment (Over-the-Counter Sleep Aids, Prescription Sleep Aids), By Distribution Channel (Drug Stores, E-Commerce, Hospital Pharmacies, Retail Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Insomnia Pharmacological Treatment Market is projected to expand from USD 4.03 Billion in 2025 to USD 5.63 Billion by 2031, reflecting a CAGR of 5.73%. This sector comprises a diverse array...
January 2026
185 pages
Memory Enhancement Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Cholinesterase Inhibitors, Smart Drugs and Cognitive Enhancers, Vitamins and Supplements, Others), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Memory Enhancement Drugs Market is projected to expand from USD 7.32 Billion in 2025 to USD 9.93 Billion by 2031, registering a CAGR of 5.21%. This sector encompasses pharmaceutical product...
January 2026
180 pages
Attention Deficit Hyperactivity Disorder (ADHD) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Stimulant, Non-stimulant), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Attention Deficit Hyperactivity Disorder (ADHD) Market is projected to expand from USD 17.82 Billion in 2025 to USD 23.25 Billion by 2031, registering a CAGR of 4.53%. This market encompass...
January 2026
181 pages
Learning Disabilities Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Auditory Processing Disorder (APD), Dyscalculia, Dysgraphia, Dyslexia, Language Processing Disorder, Others), By Treatment (Assistive Technology Tools (ATT), Handwriting Training Tools, Therapy, Others), By End User (Homecare, Specialty Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Learning Disabilities Treatment Market is projected to expand from USD 21.43 Billion in 2025 to USD 31.16 Billion by 2031, registering a CAGR of 6.44%. This market comprises pharmaceutical...
January 2026
185 pages
Schizophrenia Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), By Route Of Administration (Injectable, Oral), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Schizophrenia Drugs Market is projected to expand from USD 6.45 Billion in 2025 to USD 8.48 Billion by 2031, registering a compound annual growth rate of 4.67%. This market encompasses a va...
January 2026
180 pages
Epilepsy Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drugs (First Generation Anti-epileptics, Second Generation Anti-epileptics, Third Generation Anti-epileptics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), By Region & Competition,, 2021-2031F
US$ 4,500.00
The Global Epilepsy Drugs Market is projected to expand from USD 7.16 Billion in 2025 to USD 8.59 Billion by 2031, reflecting a CAGR of 3.08%. This industry sector encompasses the development and sale...
January 2026
186 pages
Multiple System Atrophy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Diagnosis (Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Tilt Table Test, Others), By Age (Pediatric, Adults, Geriatric), By End User (Hospitals, Ambulatory Surgical Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Multiple System Atrophy Market is projected to expand from USD 154.39 Million in 2025 to USD 185.53 Million by 2031, reflecting a Compound Annual Growth Rate of 3.11%. This market involves...
January 2026
180 pages
Post-traumatic Stress Disorder Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Antidepressants, Antipsychotics, Anti-anxiety, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Post-traumatic Stress Disorder Treatment Market is projected to expand from USD 969.39 Million in 2025 to USD 1280.63 Million by 2031, registering a CAGR of 4.75% during the forecast period...
January 2026
181 pages
Narcolepsy Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Narcolepsy with Cataplexy, Narcolepsy Without Cataplexy, Secondary Narcolepsy), By Product (Central Nervous System Stimulants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Tricyclic Antidepressants, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Narcolepsy Therapeutics Market is projected to expand from a valuation of USD 3.42 Billion in 2025 to USD 5.09 Billion by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 6.85%. The...
January 2026
180 pages
Disruptive Behavior Disorder Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Oppositional Defiant Disorder, Conduct Disorder, and Intermittent Explosive Disorder), By Treatment (Medication Management, Comprehensive Evaluation, Family Therapy, Parenting Modification, Group Therapy, Individual Therapy, and Social and Emotional Skills Training), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Disruptive Behavior Disorder Treatment Market is projected to expand from USD 1.86 million in 2025 to USD 2.57 million by 2031, registering a compound annual growth rate of 5.54%. This mark...
January 2026
180 pages
Alzheimer's Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Cholinesterase Inhibitors {Donepezil, Galantamine, Rivastigmine}, NMDA Receptor Antagonist, Combination Drugs, Pipeline Drugs), By End User (Hospital Pharmacy, Retail Pharmacy, E-commerce), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Alzheimer?s Therapeutics Market is projected to expand from USD 4.92 Billion in 2025 to USD 7.77 Billion by 2031, reflecting a compound annual growth rate (CAGR) of 7.92%. Alzheimer?s thera...
January 2026
186 pages
Central Nervous System Therapeutics Market ? Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Multiple Sclerosis, Antipsychotic, Antiepileptics, Analgesics & Anesthetics, Anti-Parkinson, Others), By Application (Neurodegenerative Diseases, Mental Health and Trauma, Neurovascular Diseases, Infectious Diseases, CNS Cancer, Others), By Route of Administration (Oral, Parenteral, Others), By End User (Hospital, Clinics, Diagnostic Laboratories, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Central Nervous System Therapeutics Market is projected to expand from USD 115.21 billion in 2025 to USD 182.42 billion by 2031, reflecting a CAGR of 7.96%. These therapeutics consist of ph...
January 2026
185 pages
Lewy Body Dementia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), By Drug Type (Cholinesterase Inhibitors, Antipsychotic Drugs, Carbidopa-Levodopa, Antidepressants, Benzodiazepine, Modafinil), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Lewy Body Dementia Treatment Market is projected to expand from USD 5.24 Billion in 2025 to USD 7.72 Billion by 2031, reflecting a compound annual growth rate of 6.67%. This market covers p...
January 2026
185 pages
Migraine Drugs Market - 2023
US$ 2,999.00
The Migraine Drugs Market was valued at 10.90 billion in 2023 and is anticipated to reach by , at a CAGR of 0.103 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, inc...
January 2026
200 pages
Cocaine Intoxication Drugs Market 2026
US$ 2,999.00
The Cocaine Intoxication Drugs Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including re...
January 2026
217 pages
Dopamine Agonists Market - 2024-2033
US$ 2,999.00
The Dopamine Agonists Market was valued at US$ 1,148.88 Million in 2024 and is anticipated to reach US$ 1,732.41 Million by 2033, at a CAGR of 0.054 from 2026 to 2032. The report delivers in-depth ins...
January 2026
217 pages
Antipsychotic Drugs Market - 2024-2033
US$ 2,999.00
The Antipsychotic Drugs Market was valued at US$ 16.41 Billion in 2024 and is anticipated to reach US$ 36.05 Billion by 2033, at a CAGR of 0.092 from 2026 to 2032. The report delivers in-depth insight...
January 2026
219 pages
The 2027-2032 World Outlook for Lou Gehrig's Disease Drugs
US$ 1,195.00
... study covers the world outlook for Lou Gehrig's Disease drugs across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for Lou Gehrig's Disease drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
Global Narcolepsy Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... Market Segment by Applications, can be divided into Daytime Extreme Sleepiness Cataplexia Others There are 15 Chapters to deeply display the global Narcolepsy Drug market. Chapter 1, to describe Narcolepsy Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Narcolepsy Drug, with ...
January 2026
77 pages
